Similar articles

• Treatment of cytomegalovirus pneumonia after bone marrow transplantation with cytomegalovirus immunoglobulin combined with ganciclovir.

  Verdonck LF, de Gast GC, Dekker AW, de Weger RA, Schuurman HJ, Rozenberg-Arska M. Verdonck LF, et al. Bone Marrow Transplant. 1989 Mar;4(2):187-9. Bone Marrow Transplant. 1989. PMID: 2539877
• [Incidence, therapy and prevention of cytomegalovirus disease after bone marrow transplantation].

  Schuler U, Ehninger G. Schuler U, et al. Med Klin (Munich). 1992 Oct;87 Suppl 1:30-8. Med Klin (Munich). 1992. PMID: 1334220 Review. German. No abstract available.
• Ganciclovir and standard high-dose immunoglobulins for the treatment of cytomegalovirus interstitial pneumonia in a bone marrow recipient.

  Iori AP, Gentile G, Petasecca Donati P, Arcese W, Martino P, Mandelli F. Iori AP, et al. Haematologica. 1990 Jul-Aug;75(4):394-6. Haematologica. 1990. PMID: 2177441
• Cytomegalovirus infection and prophylaxis in heart transplantation.

  Laske A, Gallino A, Carrel T, Niederhäuser U, von Segesser LK, Turina MI. Laske A, et al. Transplant Proc. 1993 Feb;25(1 Pt 2):1427-8. Transplant Proc. 1993. PMID: 8382870 Clinical Trial. No abstract available.
• Treatment of CMV infections and disease in transplantation.

  Schmidt GM. Schmidt GM. Transplant Proc. 1991 Jun;23(3 Suppl 3):126-9, discussion 129-30. Transplant Proc. 1991. PMID: 1648816 Review. No abstract available.